NCT06220032 2026-01-05HO170DLBCLStichting Hemato-Oncologie voor Volwassenen NederlandPhase 3 Recruiting324 enrolled
NCT03098589 2025-03-30Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)CelgeneCompleted1,149 enrolled